Ancient gout drug may protect modern heart valves
NCT ID NCT07411768
Summary
This study is testing whether a low daily dose of colchicine, an anti-inflammatory drug, can prevent blood clots from forming on new artificial heart valves after TAVR surgery. About 116 older adults (ages 60-85) who have had successful TAVR will be randomly assigned to take colchicine plus standard care or just standard care for one year. Researchers will use special CT scans to compare clot rates between the groups and monitor for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSCATHETER AORTIC VALVE REPLACEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, 100037, China
Conditions
Explore the condition pages connected to this study.